|
Consolidated Statements of Income (USD $) In Millions, except Per Share data, unless otherwise specified
|
3 Months Ended |
|
Mar. 31, 2015
|
Mar. 31, 2014
|
| Revenues |
|
|
| Premiums |
$ 7,402 |
$ 6,676 |
| Fees and other revenues |
1,138 |
1,006 |
| Net investment income |
276 |
277 |
| Mail order pharmacy revenues |
578 |
495 |
| Realized investment gains (losses): |
|
|
| Total realized investment gains |
73 |
42 |
| Total revenues |
9,467 |
8,496 |
| Benefits and Expenses |
|
|
| Global Health Care medical costs |
4,604 |
4,031 |
| Other benefit expenses |
1,269 |
1,166 |
| Mail order pharmacy cost of goods sold |
492 |
414 |
| Other operating expenses |
2,204 |
1,980 |
| Amortization of other acquired intangible assets |
44 |
52 |
| Total benefits and expenses |
8,613 |
7,643 |
| Income before Income Taxes |
854 |
853 |
| Income taxes: |
|
|
| Current |
308 |
310 |
| Deferred |
15 |
14 |
| Total taxes |
323 |
324 |
| Net Income |
531 |
529 |
| Less: Net Income Attributable to Noncontrolling Interests |
(2) |
1 |
| Shareholders' Net Income |
$ 533 |
$ 528 |
| Shareholders' Net Income Per Share: |
|
|
| Basic |
$ 2.08 |
$ 1.96 |
| Diluted |
$ 2.04 |
$ 1.92 |
| Dividends Declared Per Share |
$ 0.04 |
$ 0.04 |